Sheng X, Nenseth HZ, Qu S, Kuzu OF, Frahnow T, Simon L, Greene S, Zeng Q, Fazli L, Rennie PS, Mills IG, Danielsen H, Theis F, Patterson JB, Jin Y, Saatcioglu F(2024) Author Correction: IRE1α-XBP1s pathway promotes prostate cancer by activating c-MYC signaling Nat Commun, 15(1), 6190 DOI 10.1038/s41467-024-50645-x, PubMed 39043728
Skånland SS, Okkenhaug K, Davids MS(2024) PI3K inhibitors in hematology: When one door closes… Clin Cancer Res(in press) DOI 10.1158/1078-0432.CCR-24-0967, PubMed 38967552
Netskar H, Pfefferle A, Goodridge JP, Sohlberg E, Dufva O, Teichmann SA, Brownlie D, Michaëlsson J, Marquardt N, Clancy T, Horowitz A, Malmberg KJ(2024) Pan-cancer profiling of tumor-infiltrating natural killer cells through transcriptional reference mapping Nat Immunol(in press) DOI 10.1038/s41590-024-01884-z, PubMed 38956379